▲ S&P 500 + | ▲ Stock Advisor + Join The Motley Fool

Accessibility Log In Help

Michael Dean McGrady Jr

XMFpolicywonk

Michael McGrady is a journalist who covers public health policy, tobacco, vaping, drug legalization, industrial hemp, biotechnology, hospital systems, and food processing. He is a visiting fellow in drug and tobacco harm reduction policy at the American Consumer Institute Center for Citizen Research in Washington, D.C.

Recent Articles by Michael Dean McGrady Jr

GettyImages-1222864885

Jun 2, 2020 by Michael Dean McGrady Jr

Remdesivir Pricing Is Still A Stye In the Eye of Gilead Sciences

If Gilead Sciences' history with drug pricing is any indication, there could be a case of unavoidable controversies.

vaccine-injection-580

Jun 2, 2020 by Michael Dean McGrady Jr

British American Tobacco's COVID-19 Vaccine May Enter Trials

Tobacco vaccine production is a surprisingly economical endeavor, saving time and costs. Kentucky Bioprocessing, the biotechnology subsidiary of British American Tobacco, is leading the way.

hypodermic needles syringe drug pharma

Jun 1, 2020 by Michael Dean McGrady Jr

Merck Scored Government Backing For Its COVID-19 Vaccine. Does This Give It A Leg Up Over Players Like Novavax?

Merck's entrance into the race for a coronavirus vaccine is bolstered by a grant from the government. Does this give Merck a leg up over Novavax?

hypodermic needles syringe drug pharma

Jun 1, 2020 by Michael Dean McGrady Jr

Amid COVID-19 Therapy Push, Recent FDA News Makes Diffusion Pharmaceuticals a Buy

Diffusion Pharmaceuticals is receiving pre-investigational FDA approval for its COVID-19 therapy entry.

pigs

May 28, 2020 by Michael Dean McGrady Jr

Tyson Foods Was Slapped With a Federal Wrongful Death Lawsuit. It's About Time.

The meatpacking giant's struggle with the coronavirus pandemic highlights the future of ethically sourced meat and plant-based meat replacements.

money bag full of cash hundred bills

May 27, 2020 by Michael Dean McGrady Jr

The Government Accountability Office Offers a Look at the COVID-19 Manufacturing Process

Novavax and Regeneron are strong competitors to highlight the GAO's break down of vaccine science.

businessman with scale weighing money

May 18, 2020 by Michael Dean McGrady Jr

Philip Morris, Altria Facing ITC Investigations; What Should Investors Know?

The U.S. International Trade Commission has announced a probe into Altria and Philip Morris for alleged patent violations over IQOS heat-not-burn technology.

May 15, 2020 by Michael Dean McGrady Jr

Moderna and Novavax are Making Strides in Advancing Novel Coronavirus Vaccine Research

The biotechnology companies creating COVID-19 vaccines should give hope to patients and investors. Moderna and Novavax are no exception.

May 13, 2020 by Michael Dean McGrady Jr

Workers Are Dying at Meatpacking Plants, and Investors Need to Take Note

Thousands of coronavirus cases have been linked to meatpacking plants. Are Tyson and its peers doing enough to protect employees and the public?

dome of US Capitol Building with American flag waving in foreground -- Washington DC capital politics policy government Congress

May 11, 2020 by Michael Dean McGrady Jr

The Government Will Distribute Gilead's Remdesivir. This Could Be Bad News for Investors

There are reasons to be concerned about the initial distribution model for Gilead Sciences' recently green-lit Remdesivir treatment for COVID-19.

GettyImages-909176662

May 7, 2020 by Michael Dean McGrady Jr

From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now

Despite a busy few months with emergency use authorizations due to coronavirus, the Food and Drug Administration is expected to approve several new drugs in May.

May 1, 2020 by Michael Dean McGrady Jr

Trump Uses Defense Production Act to Keep Meatpackers Open. What Should Investors Think?

The Cold War-era law is once again being used by the White House to keep meatpackers including Tyson, JBS, and Cargill operating for the duration of the coronavirus pandemic.

Apr 27, 2020 by Michael Dean McGrady Jr

Here's Why Trump Invoking The Defense Production Act Could Help Medtronic, GE, and Other Ventilator Makers

A Cold War-era law is being used to encourage manufacturers to produce and distribute critical supplies to healthcare workers.

tractor_580-PXOMTW

Apr 22, 2020 by Michael Dean McGrady Jr

Does British American Tobacco's COVID-19 Vaccine Make It a Buy?

The science behind plant-based vaccines, including those developed using tobacco plants, could offer the opportunity for quickly developed therapies.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services